Julian S Gangolli

CIK 1532023 · President, North America · last filed 2025-10-03

Julian S Gangolli is a President, North America who has filed 49 SEC Form 4 insider transactions across 6 companies since 2011. The most recent filing, for OTLK, was dated Oct 3, 2025. Across all open-market trades the lifetime net is −$27.4M, making them a net seller over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

6

Total Filings

49

Lifetime Open-Market Net

-$27.38M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
OTLK Director $1.22 $0 7 2025-10-03
KRYS Director 0 $317.97 $0 -$3.28M 8 2025-06-30
Revance Therapeutics, Inc. (RVNC) Delisted Director 15,000 $3.65 $54.8K $0 11 2025-02-06
Outlook Therapeutics, Inc. (OTLKW) Delisted Director $0.03 $0 6 2021-10-07
GW PHARMACEUTICALS PLC (GWPH) Delisted President, North America 117,336 $218.96 $25.69M -$10.05M 2 2019-05-14
ALLERGAN INC (AGN) Delisted CVP & Pres, North America 22,496 -$14.05M 14 2015-02-24

Recent Filings

49 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2025-10-03 OTLK Grant (A) $0 EDGAR
2025-06-30 KRYS Grant (A) $0 EDGAR
2025-02-06 Revance Therapeutics, Inc. (RVNC) Delisted Mixed −45,106 -$109.9K EDGAR
2024-10-03 OTLK Grant (A) $0 EDGAR
2024-07-01 KRYS Grant (A) $0 EDGAR
2024-05-22 KRYS Mixed -$2.83M EDGAR
2024-05-03 Revance Therapeutics, Inc. (RVNC) Delisted Grant (A) +15,000 $0 EDGAR
2024-03-08 OTLK Grant (A) $0 EDGAR
2023-10-06 OTLK Grant (A) $0 EDGAR
2023-07-03 KRYS Grant (A) $0 EDGAR
Showing 110 of 49
Page 1 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.